Changes in the expression of insulin-like growth factor 1 variants in the postnatal brain development and in neonatal hypoxia-ischaemia

International Journal of Developmental Neuroscience

Volumn 28, Issue 1, 2010, Pages 91-97

  Beresewicz, Małgorzata ^a   Majewska, Monika ^a   Makarewicz, Dorota ^a   Vayro, Steven ^b   Zabłocka, Barbara ^a   Górecki, Dariusz C ^b  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^b UNIVERSITY OF PORTSMOUTH   (United Kingdom)

Author keywords

Brain development; Hypoxia; IGF 1Ea; IGF 1Ec (MGF); Ischaemia; Neonatal stroke

Indexed keywords

INSULIN LIKE GROWTH FACTOR 1 EA; INSULIN LIKE GROWTH FACTOR 1 EC; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DEVELOPMENT; BRAIN HYPOXIA; BRAIN ISCHEMIA; CONTROLLED STUDY; EMBRYO; FEMALE; MALE; NERVE CELL; NEUROPATHOLOGY; NEUROPROTECTION; NEWBORN; NEWBORN HYPOXIA; NONHUMAN; NUCLEOTIDE SEQUENCE; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN VARIANT; RAT;

ANIMALS; ANIMALS, NEWBORN; BRAIN; CELL DIFFERENTIATION; CELL LINE, TUMOR; FEMALE; HYPOXIA, BRAIN; HYPOXIA-ISCHEMIA, BRAIN; INSULIN-LIKE GROWTH FACTOR I; MALE; NEURONS; PROTEIN ISOFORMS; RATS; RATS, WISTAR; RNA, MESSENGER; TIME FACTORS;

RATTUS;

EID: 74449093772     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2009.09.002     Document Type: Article

References (61)

1. Aberg N.D., Brywe K.G., and Isgaard J. Aspects of growth hormone and insulin-like growth factor-I related to neuroprotection, regeneration, and functional plasticity in the adult brain. ScientificWorldJournal 6 (2006) 53-80
2. Aperghis M., Johnson I.P., Cannon J., Yang S.Y., and Goldspink G. Different levels of neuroprotection by two insulin-like growth factor-I splice variants. Brain Res. 1009 (2004) 213-218
3. Ayer-le Lievre C., Stahlbom P.A., and Sara V.R. Expression of IGF-I and -II mRNA in the brain and craniofacial region of the rat fetus. Development 111 (1991) 105-115
4. Bach M.A., Shen-Orr Z., Lowe Jr. W.L., Roberts Jr. C.T., and LeRoith D. Insulin-like growth factor I mRNA levels are developmentally regulated in specific regions of the rat brain. Brain Res. Mol. Brain Res. 10 (1991) 43-48
5. Blomgren K., and Hagberg H. Free radicals, mitochondria, and hypoxia-ischemia in the developing brain. Free Radic. Biol. Med. 40 (2006) 388-397
6. Bondy C., Werner H., Roberts Jr. C.T., and LeRoith D. Cellular pattern of type-I insulin-like growth factor receptor gene expression during maturation of the rat brain: comparison with insulin-like growth factors I and II. Neuroscience 46 (1992) 909-923
7. Bondy C.A. Transient IGF-I gene expression during the maturation of functionally related central projection neurons. J. Neurosci. 11 (1991) 3442-3455
8. Bondy C.A., and Cheng C.M. Signaling by insulin-like growth factor 1 in brain. Eur. J. Pharmacol. 490 (2004) 25-31
9. Brywe K.G., Leverin A.L., Gustavsson M., Mallard C., Granata R., Destefanis S., Volante M., Hagberg H., Ghigo E., and Isgaard J. Growth hormone-releasing peptide hexarelin reduces neonatal brain injury and alters Akt/glycogen synthase kinase-3{beta} phosphorylation. Endocrinology 146 (2005) 4665-4672
10. Brywe K.G., Mallard C., Gustavsson M., Hedtjarn M., Leverin A.L., Wang X., Blomgren K., Isgaard J., and Hagberg H. IGF-I neuroprotection in the immature brain after hypoxia-ischemia, involvement of Akt and GSK3beta?. Eur. J. Neurosci. 21 (2005) 1489-1502
11. Carpenter V., Matthews K., Devlin G., Stuart S., Jensen J., Conaglen J., Jeanplong F., Goldspink P., Yang S.Y., Goldspink G., Bass J., and McMahon C. Mechano-growth factor reduces loss of cardiac function in acute myocardial infarction. Heart Lung Circ. 17 (2008) 33-39
12. Clawson T.F., Vannucci S.J., Wang G.M., Seaman L.B., Yang X.L., and Lee W.H. Hypoxia-ischemia-induced apoptotic cell death correlates with IGF-I mRNA decrease in neonatal rat brain. Biol. Signals Recept. 8 (1999) 281-293
13. Connor B., and Dragunow M. The role of neuronal growth factors in neurodegenerative disorders of the human brain. Brain Res. Brain Res. Rev. 27 (1998) 1-39
14. Denti L., Annoni V., Cattadori E., Salvagnini M.A., Visioli S., Merli M.F., Corradi F., Ceresini G., Valenti G., Hoffman A.R., and Ceda G.P. Insulin-like growth factor 1 as a predictor of ischemic stroke outcome in the elderly. Am. J. Med. 117 (2004) 312-317
15. Denti L., Banchini A., Caporotundo S., Giordano A., Rocci A., Merli M.F., Annoni V., Salimbeni I., Mazzoni S., Ablondi F., Valenti G., and Ceda G.P. IGF system in acute ischemic stroke. J. Endocrinol. Invest. 25 (2002) 55-56
16. Dimopoulou I., Kouyialis A.T., Orfanos S., Armaganidis A., Tzanela M., Thalassinos N., and Tsagarakis S. Endocrine alterations in critically ill patients with stroke during the early recovery period. Neurocrit. Care 3 (2005) 224-229
17. Dluzniewska J., Sarnowska A., Beresewicz M., Johnson I.P., Srai S.K.S., Ramesh B., Goldspink G., Gorecki D.C., and Zablocka B. A strong neuroprotective effect of the autonomous C-terminal peptide of IGF-1 Ec (MGF) in brain ischemia. FASEB J. 19 (2005) 1896-1898
18. Dodge J.C., Haidet A.M., Yang W., Passini M.A., Hester M., Clarke J., Roskelley E.M., Treleaven C.M., Rizo L., Martin H., Kim S.H., Kaspar R., Taksir T.V., Griffiths D.A., Cheng S.H., Shihabuddin L.S., and Kaspar B.K. Delivery of AAV-IGF-1 to the CNS extends survival in ALS mice through modification of aberrant glial cell activity. Mol. Ther. 16 (2008) 1056-1064
19. Donahue C.P., Kosik K.S., and Shors T.J. Growth hormone is produced within the hippocampus where it responds to age, sex, and stress. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 6031-6036
20. Frago L.M., Paneda C., Dickson S.L., Hewson A.K., Argente J., and Chowen J.A. Growth hormone (GH) and GH-releasing peptide-6 increase brain insulin-like growth factor-I expression and activate intracellular signaling pathways involved in neuroprotection. Endocrinology 143 (2002) 4113-4122
21. Goldspink G. Impairment of IGF-I gene splicing and MGF expression associated with muscle wasting. Int. J. Biochem. Cell Biol. 38 (2006) 481-489
22. Gorecki D.C., Beresewicz M., and Zablocka B. Neuroprotective effects of short peptides derived from the insulin-like growth factor 1. Neurochem. Int. 51 (2007) 451-458
23. Gustafson K., Hagberg H., Bengtsson B.A., Brantsing C., and Isgaard J. Possible protective role of growth hormone in hypoxia-ischemia in neonatal rats. Pediatr. Res. 45 (1999) 318-323
24. Hodge R.D., D'Ercole A.J., and O'Kusky J.R. Insulin-like growth factor-I (IGF-I) inhibits neuronal apoptosis in the developing cerebral cortex in vivo. Int. J. Dev. Neurosci. 25 (2007) 233-241
25. Hurn P.D., Vannucci S.J., and Hagberg H. Adult or perinatal brain injury: does sex matter?. Stroke 36 (2005) 193-195
26. Hwang I.K., Yoo K.Y., Park S.K., An S.J., Lee J.Y., Choi S.Y., Kang J.H., Kwon Y.G., Kang T.C., and Won M.H. Expression and changes of endogenous insulin-like growth factor-1 in neurons and glia in the gerbil hippocampus and dentate gyrus after ischemic insult. Neurochem. Int. 45 (2004) 149-156
27. Jantzie L.L., Cheung P.Y., Obaid L., Emara M., Johnson S.T., Bigam D.L., and Todd K.G. Persistent neurochemical changes in neonatal piglets after hypoxia-ischemia and resuscitation with 100%, 21% or 18% oxygen. Resuscitation 77 (2008) 111-120
28. Johnsen S.P., Hundborg H.H., Sorensen H.T., Orskov H., Tjonneland A., Overvad K., and Jorgensen J.O. Insulin-like growth factor (IGF) I, -II, and IGF binding protein-3 and risk of ischemic stroke. J. Clin. Endocrinol. Metab. 90 (2005) 5937-5941
29. Jones N.M., Kardashyan L., Callaway J.K., Lee E.M., and Beart P.M. Long-term functional and protective actions of preconditioning with hypoxia, cobalt chloride, and desferrioxamine against hypoxic-ischemic injury in neonatal rats. Pediatr. Res. 63 (2008) 620-624
30. Kadam S.D., Mulholland J.D., McDonald J.W., and Comi A.M. Neurogenesis and neuronal commitment following ischemia in a new mouse model for neonatal stroke. Brain Res. 1208 (2008) 35-45
31. Klejman M.E., Gruszczynska-Biegala J., Skibinska-Kijek A., Wisniewska M.B., Misztal K., Blazejczyk M., Bojarski L., and Kuznicki J. Expression of STIM1 in brain and puncta-like co-localization of STIM1 and ORAI1 upon depletion of Ca(2+) store in neurons. Neurochem. Int. 54 (2009) 49-55
32. Kravchenko I.V., Furalyov V.A., Khotchenkov V.P., and Popov V.O. Monoclonal antibodies to mechano-growth factor. Hybridoma (Larchmt.) 25 (2006) 300-305
33. Lin S., Fan L.W., Pang Y., Rhodes P.G., Mitchell H.J., and Cai Z. IGF-1 protects oligodendrocyte progenitor cells and improves neurological functions following cerebral hypoxia-ischemia in the neonatal rat. Brain Res. 1063 (2005) 15-26
34. Liu X.F., Fawcett J.R., Thorne R.G., DeFor T.A., and Frey W.H. Intranasal administration of insulin-like growth factor-I bypasses the blood-brain barrier and protects against focal cerebral ischemic damage. J. Neurol. Sci. 187 (2001) 91-97
35. McCarthy J.J., Esser K.A., and Andrade F.H. MicroRNA-206 is overexpressed in the diaphragm but not the hindlimb muscle of mdx mouse. Am. J. Physiol. Cell Physiol. 293 (2007) C451-C457
36. Musaro A., Dobrowolny G., and Rosenthal N. The neuroprotective effects of a locally acting IGF-1 isoform. Exp. Gerontol. 42 (2006) 76-80
37. O'Donnell S.L., Frederick T.J., Krady J.K., Vannucci S.J., and Wood T.L. IGF-I and microglia/macrophage proliferation in the ischemic mouse brain. Glia 39 (2002) 85-97
38. Osborne R. Commercial interest waxes for IGF-1 blockers. Nat. Biotechnol. 26 (2008) 719-720
39. Peruzzi F., Prisco M., Dews M., Salomoni P., Grassilli E., Romano G., Calabretta B., and Baserga R. Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis. Mol. Cell. Biol. 19 (1999) 7203-7215
40. Peruzzi F., Prisco M., Morrione A., Valentinis B., and Baserga R. Anti-apoptotic signaling of the insulin-like growth factor-I receptor through mitochondrial translocation of c-Raf and Nedd4. J. Biol. Chem. 276 (2001) 25990-25996
41. Riva C., Donadieu E., Magnan J., and Lavieille J.P. Age-related hearing loss in CD/1 mice is associated to ROS formation and HIF target proteins up-regulation in the cochlea. Exp. Gerontol. 42 (2007) 327-336
42. Robertson C.M., Finer N.N., and Grace M.G. School performance of survivors of neonatal encephalopathy associated with birth asphyxia at term. J. Pediatr. 114 (1989) 753-760
43. Russo V.C., Gluckman P.D., Feldman E.L., and Werther G.A. The insulin-like growth factor system and its pleiotropic functions in brain. Endocr. Rev. 26 (2005) 916-943
44. Satar M., Ozcan K., Yapicioglu H., and Narli N. Serum insulin-like growth factor 1 and growth hormone levels of hypoxic-ischemic newborns. Biol. Neonate 85 (2004) 15-20
45. Schabitz W.R., Hoffmann T.T., Heiland S., Kollmar R., Bardutzky J., Sommer C., and Schwab S. Delayed neuroprotective effect of insulin-like growth factor-I after experimental transient focal cerebral ischemia monitored with MRI. Stroke 32 (2001) 1226-1233
46. Seigel G.M., Lupien S.B., Campbell L.M., and Ishii D.N. Systemic IGF-I treatment inhibits cell death in diabetic rat retina. J. Diabetes Complications 20 (2006) 196-204
47. Shankaran S., Woldt E., Koepke T., Bedard M.P., and Nandyal R. Acute neonatal morbidity and long-term central nervous system sequelae of perinatal asphyxia in term infants. Early Hum. Dev. 25 (1991) 135-148
48. Stein D.G. Brain damage, sex hormones and recovery: a new role for progesterone and estrogen?. Trends Neurosci. 24 (2001) 386-391
49. Subramaniam S., Shahani N., Strelau J., Laliberte C., Brandt R., Kaplan D., and Unsicker K. Insulin-like growth factor 1 inhibits extracellular signal-regulated kinase to promote neuronal survival via the phosphatidylinositol 3-kinase/protein kinase A/c-Raf pathway. J. Neurosci. 25 (2005) 2838-2852
50. Sudlow C.L., and Warlow C.P. Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. International Stroke Incidence Collaboration. Stroke 28 (1997) 491-499
51. Tan D.S., Cook A., and Chew S.L. Nucleolar localization of an isoform of the IGF-I precursor. BMC. Cell Biol. 3 (2002) 17-22
52. Trejo J.L., Llorens-Martin M.V., and Torres-Aleman I. The effects of exercise on spatial learning and anxiety-like behavior are mediated by an IGF-I-dependent mechanism related to hippocampal neurogenesis. Mol. Cell. Neurosci. 37 (2008) 402-411
53. Vagnerova K., Koerner I.P., and Hurn P.D. Gender and the injured brain. Anesth. Analg. 107 (2008) 201-214
54. van den Tweel E.R., Kavelaars A., Lombardi M.S., Nijboer C.H., Groenendaal F., van Bel F., and Heijnen C.J. Bilateral molecular changes in a neonatal rat model of unilateral hypoxic-ischemic brain damage. Pediatr. Res. 59 (2006) 434-439
55. van Rijn M.J., Slooter A.J., Bos M.J., Catarino C.F., Koudstaal P.J., Hofman A., Breteler M.M., and van Duijn C.M. Insulin-like growth factor I promoter polymorphism, risk of stroke, and survival after stroke: the Rotterdam study. J. Neurol. Neurosurg. Psychiatry 77 (2006) 24-27
56. Wang J.M., Hayashi T., Zhang W.R., Li F., Iwai M., and Abe K. Reduction of ischemic damage by application of insulin-like growth factor-1 in rat brain after transient ischemia. Acta Med. Okayama 55 (2001) 25-30
57. Wilczak N., Elting J.W., Chesik D., Kema I.P., and De Keyser J. Intravenous tissue plasminogen activator in patients with stroke increases the bioavailability of insulin-like growth factor-1. Stroke 37 (2006) 2368-2371
58. Wood T.L., Loladze V., Altieri S., Gangoli N., Levison S.W., Brywe K.G., Mallard C., and Hagberg H. Delayed IGF-1 administration rescues oligodendrocyte progenitors from glutamate-induced cell death and hypoxic-ischemic brain damage. Dev. Neurosci. 29 (2007) 302-310
59. Yin W., Signore A.P., Iwai M., Cao G., Gao Y., Johnnides M.J., Hickey R.W., and Chen J. Preconditioning suppresses inflammation in neonatal hypoxic ischemia via Akt activation. Stroke 38 (2007) 1017-1024
60. Zalewska T., Makarewicz D., Janik B., and Ziemka-Nalecz M. Neonatal cerebral hypoxia-ischemia: involvement of FAK-dependent pathway. Int. J Dev. Neurosci. 23 (2005) 657-662
61. Zhu W., Fan Y., Frenzel T., Gasmi M., Bartus R.T., Young W.L., Yang G.Y., and Chen Y. Insulin growth factor-1 gene transfer enhances neurovascular remodeling and improves long-term stroke outcome in mice. Stroke 39 (2008) 1254-1261